A new exploratory study suggests that the peripheral nervous system — the nerves that control our sense of touch, pain and other sensations — may play a role in autism.
It may be possible to treat a troublesome chronic cough without disrupting the protective cough we need for optimal lung health by targeting the different brain circuits involved.
Researchers have uncovered a key strategy the immune system uses to generate effective antibodies, which could inform vaccine design for some challenging viruses.
By blocking an immune sensor called STING, researchers could dramatically prevent inflammation in MND patient cells, paving the way for a new class of drugs.
Johnson & Johnson says it has temporarily paused all its COVID-19 vaccine trials, and CSIRO denies that changes in the virus would affect the efficacy of vaccine candidates.
Researchers have revealed a significant increase in the prevalence of the median artery in humans since the late 19th century, suggesting that our species is still evolving.
A growing body of evidence suggests that obesity is a disease whose roots are in the brain.
Scientists have identified and characterised the gene responsible for immune cell death and inflammation during sepsis — a disease that kills 11 million people per year.
Adults conceived through sperm donation report higher frequencies of allergies, type 1 diabetes and other autoimmune conditions.
Signature brain activity in three-month-old infants has been used to predict symptoms of autism spectrum disorder that wouldn't be visible until later in life.
New fathers are flooded with prolactin — the same chemical found in breastfeeding mothers — which unlocks the paternal instinct and helps to make them better dads.
US researchers aimed to determine whether a 28-day period of disrupted sleep changed the gut microbiota in rats.
The COVID-19 vaccine trial, which has produced positive indications about its potential effectiveness and manufacturability, is being expanded to an older demographic.
Researchers have identified mechanisms leading to the functional deterioration of the immune system in response to severe viral infections, such as HIV or COVID-19.
Intravacc has published the phase I study results of its vaccine candidate for respiratory syncytial virus — a major cause of lower respiratory tract infections.